7.10
+0.12(+1.72%)
Currency In USD
Previous Close | 6.98 |
Open | 7.01 |
Day High | 7.21 |
Day Low | 6.98 |
52-Week High | 9.34 |
52-Week Low | 4.92 |
Volume | 255,220 |
Average Volume | 335,956 |
Market Cap | 186.83M |
PE | -2.43 |
EPS | -2.92 |
Moving Average 50 Days | 7.34 |
Moving Average 200 Days | 6.56 |
Change | 0.12 |
If you invested $1000 in LogicBio Therapeutics, Inc. (LOGC) since IPO date, it would be worth $617.39 as of April 25, 2025 at a share price of $7.1. Whereas If you bought $1000 worth of LogicBio Therapeutics, Inc. (LOGC) shares 5 years ago, it would be worth $1,128.78 as of April 25, 2025 at a share price of $7.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025
GlobeNewswire Inc.
Mar 10, 2025 12:00 PM GMT
OAKLAND, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today announced it will report its fourth quarter and full year 2024 financial results after the close of market on
ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners
GlobeNewswire Inc.
Feb 25, 2025 1:00 PM GMT
Strategic investment and capital commitment positions the Company to execute on its stated acquisition-led value maximization strategy; ContextLogic to have up to $300 million of investible cash Ted Goldthorpe, Head of BC Partners Credit, expected to
ContextLogic Inc. Reports Third-Quarter 2024 Financial Results
GlobeNewswire Inc.
Nov 07, 2024 9:10 PM GMT
OAKLAND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and nine months ended September 30, 2024. Third Quarter 2024 Fi